An interventional study of Non invasive prenatal test in Miscarriage in First Trimester and Prenatal Genetic Diagnosis, sponsored by Rennes University Hospital. Recruiting at 1 site in France. Open to female participants aged 18 Years to 43 Years. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Rennes University Hospital · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Abortion, Spontaneous with a site in France — 7 open to participants now, 8 under way, none of them phase 3. Abortion, Spontaneous · France.
Among the 27 studies in Abortion, Spontaneous with a site in France, this one is the 11th largest by planned enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2026, is one of 12 with no phase, and was the 27th registered.
221 studies on the registry are indexed under Abortion, Spontaneous; 44 are open to participants now.
Browse Abortion, Spontaneous studies →7 of the 27 studies in Abortion, Spontaneous with a site in France are open now. Recruiting first, the newest first:
University Hospital, Toulouse · Sites in France
Ages up to 18 · Women only
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
University Hospital, Montpellier · Sites in France
Ages 18–42 · Women only
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18–50 · Women only
University Hospital, Brest · Sites in France
Ages 18–40
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 36 Abortion, Spontaneous studies recruiting now, 11 (31%) set no upper age limit and 25 (69%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 43 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 100 is below the median of 150 across 120 interventional studies indexed under Abortion, Spontaneous.
Median enrollment 210 across the 14 interventional studies, 202 across the 13 observational. Of the 15 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 27 have an industry lead sponsor. The 10 most frequent:
Rennes University Hospital is the lead sponsor of 451 studies on the registry; 51 are open to participants now.
Rennes University Hospital has 1 study filed under Abortion, Spontaneous — fewer than ten, so there is no comparison to draw.
5 of the studies in Abortion, Spontaneous with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06576622University Hospital, ToulousePERIodontal Disease, Microbiota and Miscarriage | 2026-12-30 |
| NCT07732231Nantes University HospitalCost-utility Analysis of Outpatient Manual Vacuum Aspiration Versus Operating Room Electric Aspiration for the Management of First-trimester Miscarriage | 2027-01-01 |
| NCT06647849University Hospital, AngersInterest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients | 2027-06-11 |
| NCT05789940University Hospital, MontpellierHysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention | 2027-09-18 |
| NCT05557201Assistance Publique - Hôpitaux de ParisCohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors | 2027-10 |
Add all 5 to your calendar (.ics) → With an account.
Among the 27 studies in Abortion, Spontaneous with a site in France, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage
A blood sample will be added to primary care at the time of diagnosis of early miscarriage to realise non-invasive prenatal testing (NIPT). NIPT will be done on cell-free fetal DNA present in woman's blood to detect potential chromosomal abnormalities. At the 8-week consultation, the results will be shared with the patient if she so wishes. During this appointment, two questionnaires designed to assess her psychological state in relation to the miscarriage (HAD and PGS) will be completed. Depending on the patient's medical history and the results of the NIPT, a tailored care plan may be proposed. At the one-year follow-up appointment, the same questionnaires will be completed and a review will be carried out of the care proposed and provided, as well as the couple's future reproductive plans.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Expulsion of a pregnancy within the last 2 hours
Exclusion Criteria:
Genetic: Non invasive prenatal test
cell free fetal DNA analysis
Psychological distress score
HADS (Hospital Anxiety and Depression Scale) and PGS (Perinatal Grief Scale) scores. The impact of the NIPT results will be analyzed in relation to these scores, which will be combined into a composite score of psychological distress. HADS questionnaire : Each item is rated on a four-point scale, giving maximum scores of 21 for anxiety and depression. Scores of 11 or more on either subscale are considered to be a significant 'case' of psychological morbidity, while scores of 8-10 represents 'borderline' and 0-7 'normal' The PGS is a self-report questionnaire designed to assess the emotional and psychological impact of perinatal loss, including miscarriage, stillbirth, or neonatal death. The more the score is high, the more the grief is intense.
Time frame: 8 weeks
Long term Psychological distress score
HADS (Hospital Anxiety and Depression Scale) and PGS (Perinatal Grief Scale) at 1 year. The impact of the DPNI results will be analyzed in relation to these scores, which will be combined into a composite score of psychological distress. HADS questionnaire : Each item is rated on a four-point scale, giving maximum scores of 21 for anxiety and depression. Scores of 11 or more on either subscale are considered to be a significant 'case' of psychological morbidity, while scores of 8-10 represents 'borderline' and 0-7 'normal' The PGS is a self-report questionnaire designed to assess the emotional and psychological impact of perinatal loss, including miscarriage, stillbirth, or neonatal death. The more the score is high, the more the grief is intense.
Time frame: 12 months
Rate of balanced chromosomal abnormalities in a parent
Number of parents with a chromosomal rearrangement that explains the occurrence of an early miscarriage
Time frame: 8 weeks
Number of modified care pathways
Number of modified care pathways based on the patient's etiology and the NIPT results during the year after miscarriages
Time frame: 12 months
Number of pregnancies
Number of pregnancies and scalability during the year, according to care pathways and NIPT results
Time frame: 12 months
Plan to share: Yes — All of the individual participant data collected during the trial will be available, after the primary publication of the results, to any researchers who provide a methodologically sound proposal. Proposals should be directed to dri@chu-rennes.fr. To gain access, data requestors will need to sign a data access agreement; depending on the case, additional formalities may be required.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: Data availability after the primary publication of the results and until the database is deleted
Access criteria: Any researchers who provide a methodologically sound proposal will be able to access the IPD ans supporting information. To gain access, data requestors will need to sign a data access agreement; depending on the case, additional formalities may be required.
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Mar 2028, 18 months after the start.
Of 43 non-industry interventional studies with no phase under Abortion, Spontaneous, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 18 months is below that.
Counting every sponsor, half of 45 studies reached it within 27 months; a quarter within 12 and three quarters within 40.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.